Companies: 10,795·Total market cap: $144.5T
Biophytis S.A.

Biophytis S.A.

BPTSNASDAQHealthcare
$8.22
$-1.28(-13.47%)
Market Cap$2608625
P/E Ratio
52W High$168.8
52W Low$8.05
Overview

Biophytis S.A. (BPTS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

bpts · pe ratio · data through Dec 31, 2023

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Biophytis S.A. (BPTS) measures how much investors pay for each dollar of the company's trailing earnings. BPTS's current PE ratio of N/A is calculated by dividing its stock price of $8.22 by its TTM earnings per share of -$0.42.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31

Forward P/E
N/A
Based on 0 analysts
EPS (TTM)
-$0.42
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Biophytis S.A. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2012 – 2023 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Biophytis S.A.
Biophytis S.A.You
BPTS
$3MN/A-$0.42
Affimed N.V.
Affimed N.V.
AFMD
$3MN/A-$7.09
Aravive, Inc.
Aravive, Inc.
ARAV
$3MN/A-$2.22
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc.
EIGRQ
$13MN/A-$50.78
Fresh2 Group Limited
Fresh2 Group Limited
FRES
$2MN/A-$106577.06
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc.
IDRA
$0MN/A-$7.17
Novan, Inc.
Novan, Inc.
NOVN
$3MN/A-$0.89

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 12 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2023-12-31Latest
FY2023
$-12.55
2022-12-31
FY2022
$-56.06
2021-12-31
FY2021
$-105.64
2020-12-31
FY2020
$-172.41
2019-12-31
FY2019
$-451.10
2018-12-31
FY2018
$-423.85
2017-12-31
FY2017
$-518.55
2016-12-31
FY2016
$-530.27
2015-12-31
FY2015
$-436.00
2014-12-31
FY2014
$-50.64

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Biophytis S.A. (BPTS) measures how much investors pay for each dollar of the company's trailing earnings. BPTS's current PE ratio of N/A is calculated by dividing its stock price of $8.22 by its TTM earnings per share of -$0.42.

PE Ratio = Stock Price ÷ EPS (TTM)
= $8.22 ÷ -$0.42 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

BPTS pe ratio · 6 questions

BPTS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $8.22 and TTM EPS of -$0.42. Data sourced from Financial Modeling Prep via BPTS's SEC 10-K and 10-Q filings.

BPTS PE ratioWhat is BPTS PE ratioCurrent PE ratio of BPTSBPTS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Biophytis S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09